|
⚲
|
| Keyboard |
| Arkin Moshe
✚
|
|
|---|---|
| CIK # | 0001321178 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001321178] | |
| 4 | [0001321178] | |
| SC 13D | [0001321178] | |
| SC 13G | [0001321178] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Odysightai Inc ODYS
Warrants to purchase common stock · derivative
|
2026-03-25 | Option exercise | 2,352,941 | $0.00 | |
|
Odysightai Inc ODYS
Common Stock
|
2026-03-25 | Option exercise | 2,352,941 | $5.50 | 12,941,176 |
|
Odysightai Inc ODYS
Common Stock
|
2026-03-25 | Tax withheld | 2,081,044 | $5.50 | 11,445,742 |
|
Werewolf Therapeutics Inc HOWL
Series B Preferred Stock · derivative
|
2021-05-04 | Conversion | 3,560,551 | $0.00 | |
|
Werewolf Therapeutics Inc HOWL
Series A Preferred Stock · derivative
|
2021-05-04 | Conversion | 10,714,284 | $0.00 | |
|
Werewolf Therapeutics Inc HOWL
Common Stock
|
2021-05-04 | Buy | 400,000 | $16.00 | 6,400,000 |
|
Werewolf Therapeutics Inc HOWL
Common Stock
|
2021-05-04 | Conversion | 410,717 | ||
|
Werewolf Therapeutics Inc HOWL
Common Stock
|
2021-05-04 | Conversion | 1,235,917 | ||
|
Keros Therapeutics Inc KROS
Common Stock
|
2020-04-13 | Conversion | 1,382,295 | ||
|
Keros Therapeutics Inc KROS
Series A Preferred Stock · derivative
|
2020-04-13 | Conversion | 1,382,295 | $0.00 | |
|
Keros Therapeutics Inc KROS
Series B-1 Preferred Stock · derivative
|
2020-04-13 | Conversion | 343,270 | $0.00 | |
|
Keros Therapeutics Inc KROS
Series C Preferred Stock · derivative
|
2020-04-13 | Conversion | 167,537 | $0.00 | |
|
Keros Therapeutics Inc KROS
Common Stock
|
2020-04-13 | Buy | 120,000 | $16.00 | 1,920,000 |
|
Keros Therapeutics Inc KROS
Common Stock
|
2020-04-13 | Conversion | 343,270 | ||
|
Keros Therapeutics Inc KROS
Common Stock
|
2020-04-13 | Conversion | 167,537 |